Lime Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Early Stage VC
- Investors
-
13
Lime Therapeutics General Information
Description
Developer of therapeutic drugs designed to modulate aberrant lipid metabolism in many forms of cancer, metabolic diseases, and neurodegenerative disorders. The company identifies medicines that can starve cancer by blocking its vital nutrient source, enabling medical professionals to use drugs and increase survival in a non-small cell lung cancer model.
Contact Information
Website
www.limetherapeutics.comCorporate Office
- Ford Center Incubator
- 1230 York Avenue
- New York, NY 10065
- United States
Corporate Office
- Ford Center Incubator
- 1230 York Avenue
- New York, NY 10065
- United States
Lime Therapeutics Timeline
Lime Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Early Stage VC | 08-Apr-2024 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 16-Dec-2022 | Completed | Generating Revenue | |||
| 5. Grant | 16-Dec-2022 | Completed | Generating Revenue | |||
| 4. Grant | 08-Mar-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 15-Oct-2021 | Completed | Startup | |||
| 2. Seed Round | 01-Jan-2021 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Lime Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Lime Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lime Therapeutics Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Jolt VC | Venture Capital | Minority | ||
| Termeer Institute | Accelerator/Incubator | |||
| Case Western Reserve University Endowment | Limited Partner | Minority | ||
| Coho Deeptech | Venture Capital | Minority | ||
| Epakon Capital | Venture Capital | Minority |
Lime Therapeutics FAQs
-
When was Lime Therapeutics founded?
Lime Therapeutics was founded in 2021.
-
Where is Lime Therapeutics headquartered?
Lime Therapeutics is headquartered in New York, NY.
-
What is the size of Lime Therapeutics?
Lime Therapeutics has 5 total employees.
-
What industry is Lime Therapeutics in?
Lime Therapeutics’s primary industry is Drug Discovery.
-
Is Lime Therapeutics a private or public company?
Lime Therapeutics is a Private company.
-
What is Lime Therapeutics’s current revenue?
The current revenue for Lime Therapeutics is .
-
How much funding has Lime Therapeutics raised over time?
Lime Therapeutics has raised $2.6M.
-
Who are Lime Therapeutics’s investors?
Jolt VC, Termeer Institute, Case Western Reserve University Endowment, Coho Deeptech, and Epakon Capital are 5 of 13 investors who have invested in Lime Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
